Skip to content
    Back to Database
    General Health IngredientsNatural

    Resistant Starch

    Also known as: RS, resistant dietary starch, RS2/RS3/RS4 (types)

    Randomized controlled trials report that increasing RS (via cooled/reheated rice, defined RS4 fibres or RS supplements) lowers glycaemic response, shifts microbiome composition and fermentation patterns, can reduce intrahepatic triglyceride content in NAFLD, and may facilitate modest weight loss in people with overweight or obesity. Effects are linked to changes in gut microbial taxa, short‑chain fatty acids and bile acid metabolism in the cited trials.

    Last reviewed: 2026-10-14 · 5 indexed studies

    Evidence Score
    74/100
    Improve glycaemic response from starchy foodsModulate gut microbiota and increase colonic fermentationSupport weight loss and metabolic healthAdjunctive strategy in NAFLD management
    Data Completeness4/4 · 100%
    Evidence ScoreDosageSafetyLinked Studies

    Set your location for accurate regulatory status

    Saved on this device — no sign-in needed.

    Sign in to add to stack

    Overview

    Resistant starch (RS) is a fraction of dietary starch that resists digestion in the small intestine and is fermented in the colon. Human trials show RS can lower postprandial glycaemic responses, alter gut microbiota and short‑chain fatty acid production, and produce modest improvements in body weight and liver fat in metabolic disease.

    Mechanism & Function

    Mechanism of Action

    Resistant starch reaches the colon where bacterial fermentation generates short‑chain fatty acids (butyrate, propionate) and alters microbial ecology; these changes are associated with reduced postprandial glycaemia, altered bile acid profiles, reduced inflammation, decreased lipid absorption and changes in metabolites (for example branched‑chain amino acids) that relate to liver fat and body weight.

    Physiological Role

    Substrate for colonic fermentation; modulates microbial composition and metabolic outputs that influence host glucose and lipid metabolism and intestinal barrier function.

    Primary Pathways

    Colonic fermentation to short‑chain fatty acidsGut microbiota composition modulationBile acid metabolism alterationReduced small‑intestinal starch digestion/absorption

    Performance / Health Relevance

    Indirect: by improving metabolic health (glycaemia, body composition, liver fat) and gut function, RS could support health outcomes relevant to exercise and recovery, though no direct performance endpoints are reported in the provided trials.

    Evidence Review

    Overall74/100
    Human Clinical77/100
    Meta-AnalysisN/A

    No meta-analyses or systematic reviews indexed for this ingredient yet.

    Mechanistic85/100
    Real-World58/100
    Safety80/100

    Dimensions marked N/A have no indexed evidence of that class. They are shown as unavailable rather than scored.

    Practical Use & Dosage

    Minimum Effective Dose
    Not established from these abstracts; effects on microbiota were dose‑responsive with plateauing reported by 35 g/day for RS4
    Optimal Range
    Varies by RS type; one dose‑response study reported microbiome effects plateauing at ~35 g/day of RS4
    Upper / Caution Level
    Not established in the provided abstracts
    Timing
    Not specified in the abstracts; RS can be consumed as part of foods (e.g. cooled/reheated starches) or as discrete fibre supplements
    Best Format
    Depends on objective: food processing (cooled/reheated starch increases RS3) or defined RS fibres (RS4) used in trials
    Bioavailability
    Resistant starch is not digested in the small intestine and is instead fermented in the colon; effects depend on RS structure and the resident microbiota
    Absorption Considerations
    RS is not systemically absorbed; benefits are mediated via colonic fermentation and microbial metabolites

    Safety & Interactions

    Side Effects

    • •Gastrointestinal gas and bloating may occur due to fermentation (not quantified in these abstracts)

    Contraindications

    • None reported in the provided abstracts

    Drug Interactions

    • •Not reported in the provided abstracts

    Who Should Avoid

    • •Individuals with severe gastrointestinal disorders or fibre intolerance should exercise caution (general guidance; not specified in the abstracts)

    Monitoring

    Monitor gastrointestinal tolerance when initiating or increasing resistant starch intake

    Frequently Asked Questions

    Auto-generated from indexed evidence — dosage, safety, interactions, and more.

    When is Resistant Starch typically used or indicated?

    Resistant Starch is most commonly used for: Improve glycaemic response from starchy foods, Modulate gut microbiota and increase colonic fermentation, Support weight loss and metabolic health, Adjunctive strategy in NAFLD management. Substrate for colonic fermentation; modulates microbial composition and metabolic outputs that influence host glucose and lipid metabolism and intestinal barrier function.

    How does Resistant Starch work?

    Resistant starch reaches the colon where bacterial fermentation generates short‑chain fatty acids (butyrate, propionate) and alters microbial ecology; these changes are associated with reduced postprandial glycaemia, altered bile acid profiles, reduced inflammation, decreased lipid absorption and changes in metabolites (for example branched‑chain amino acids) that relate to liver fat and body weight.

    What is the recommended dose of Resistant Starch?

    The optimal range is Varies by RS type; one dose‑response study reported microbiome effects plateauing at ~35 g/day of RS4. with a minimum effective dose of Not established from these abstracts; effects on microbiota were dose‑responsive with plateauing reported by 35 g/day for RS4. Best taken: Not specified in the abstracts; RS can be consumed as part of foods (e.g. cooled/reheated starches) or as discrete fibre supplements. Upper / caution level: Not established in the provided abstracts.

    What are the side effects of Resistant Starch?

    Reported side effects include: Gastrointestinal gas and bloating may occur due to fermentation (not quantified in these abstracts). Monitoring: Monitor gastrointestinal tolerance when initiating or increasing resistant starch intake

    Does Resistant Starch interact with medications?

    Known or theoretical interactions: Not reported in the provided abstracts. Always check with a clinician before combining with prescription medication.

    Who should avoid Resistant Starch?

    Resistant Starch is generally not recommended for: Individuals with severe gastrointestinal disorders or fibre intolerance should exercise caution (general guidance; not specified in the abstracts); and None reported in the provided abstracts.

    How strong is the evidence for Resistant Starch?

    Evidence level: Moderate (overall score 74/100), based on 5 indexed studies on SuppIndex.

    Research & References (5)

    Effect of cooling of cooked white rice on resistant starch content and glycemic response.

    RCT2015
    PubMed

    Randomized single‑blind crossover in 15 healthy adults compared freshly cooked white rice with white rice cooled 24 hours at 4°C then reheated (increasing RS content).

    Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations.

    RCT2023
    PubMed

    4‑month randomized placebo‑controlled trial in individuals with NAFLD assessing RS supplementation coupled with multi‑omics analysis.

    Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota.

    RCT2024
    PubMed

    Randomized placebo‑controlled crossover trial in 37 participants with overweight or obesity testing 8 weeks of RS supplementation on body weight and insulin resistance.

    Faecal microbial transfer and complex carbohydrates mediate protection against COPD.

    RCT2024
    PubMed

    Pilot randomized, double‑blind, placebo‑controlled study component in 16 patients with COPD testing inulin (a complex carbohydrate) alongside murine experiments using high resistant starch diets; human arm assessed effects of complex carbohydrates on disease outcomes.

    Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production.

    RCT2020
    PubMed

    Dose‑response trial in healthy humans using three type‑IV resistant starches (RS4) that assessed microbiome composition and short‑chain fatty acid production across doses up to a plateau.

    Related Ingredients

    Other top-rated ingredients in General Health Ingredients.

    Piperine

    82/100

    A piperidine alkaloid (C₁₇H₁₉NO₃) that inhibits cytochrome P450 enzymes (CYP3A4, CYP1A2, CYP2E1), P-glycoprotein efflux transporters, and UDP-glucuronosyltransferases while enhancing intestinal permeability, digestive enzyme secretion, and splanchnic blood flow — collectively producing dramatic improvements in nutrient bioavailability.

    CoQ10

    78/100

    Endogenous lipid-soluble ubiquinone/ubiquinol that shuttles electrons in the mitochondrial respiratory chain and acts as a membrane antioxidant.

    Beta-Glucan (Oat)

    77/100

    Multiple randomized trials and meta-analyses report that ≥3 g/day oat beta-glucan lowers LDL and total cholesterol modestly. Acute feeding trials pooled in meta-analysis show dose- and molecular-weight–dependent reductions in postprandial glucose and insulin responses.

    Research Overview

    Moderate Evidence
    5Total Studies
    5Human Trials
    0Meta-Analyses
    2024Latest Study
    0Animal / In Vitro
    0Athlete Studies
    Primary data sourceGeneral Population
    Pooled evidence (meta-analysis / systematic review)No

    Cite this ingredient

    One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.

    Stable URL

    https://thesuppindex.com/ingredients/resistant-starch

    SuppIndex. (2026). Resistant Starch: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/resistant-starch

    Based on 5 indexed studies · Evidence level: Moderate.

    Goal Ratings

    Metabolic Health
    Fat Loss
    General Health

    Stack Compatibility

    Generally compatible with other dietary fibres and probiotic/prebiotic strategies; effects are microbiome‑dependent

    Dietary fibre blendsProbiotics/prebioticsGeneral low‑energy diets for weight loss